Contract 75N93019C00053
Duke University · Department Of Health And Human Services · July 1, 2024
Duke University was awarded a federal contract by Department Of Health And Human Services (National Institutes Of Health) on July 1, 2024 for $10.48 million of work in research and development in biotechnology (except nanobiotechnology). Performance is in Durham, NC. It was awarded under full and open competition. The contract has been modified 5 times since the base award It uses cost no fee contract pricing. The most recent modification was on September 22, 2025. If all options are exercised, the contract could reach $141.34 million.
Contract details
- PIID
- 75N93019C00053
- Award type
- Definitive Contract
- Pricing
- Cost No Fee
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 541714 · Research And Development In Biotechnology (Except Nanobiotechnology)
- Product / service
- Health R&D Services; Health Care Services; Applied Research
- Place of performance
- Durham, NC
- First action
- July 1, 2024
- Latest action
- September 22, 2025
Description
19C00053; COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) COMPONENT B: VACCINE MANUFACTURING AND TOXICOLOGY CORE.
Modification timeline
-
September 22, 2025Mod P00032 · Funding Only Action$78.20M
-
September 4, 2025Mod P00031 · Supplemental Agreement For Work Within Scope$79.03M
-
July 7, 2025Mod P00030 · Exercise An Option$77.97M
-
September 20, 2024Mod P00027 · Funding Only Action$77.44M
-
August 26, 2024Mod P00026 · Supplemental Agreement For Work Within Scope$78.51M
-
July 1, 2024Mod P00025 · Exercise An Option$74.83M
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Vericel Corporation | Department Of Health And Human Services | April 1, 2026 | $34.88M |
| American College Of Medical Toxicology, Inc. | Department Of Health And Human Services | March 31, 2026 | $0 |
| Ceramedix Holding, Llc | Department Of Health And Human Services | March 31, 2026 | $4.22M |
| Glaxosmithkline, Llc | Department Of Health And Human Services | March 31, 2026 | $7.79M |
| Care Access Research Llc | Department Of Health And Human Services | March 31, 2026 | $2.55M |
| Pattern Bioscience, Inc. | Department Of Health And Human Services | March 31, 2026 | $22.50M |
Top contractors in NAICS 541714
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Amgen USA Inc | 1 | $59.99M |
| 2 | Vericel Corporation | 1 | $34.88M |
| 3 | Spectral Md, Inc. | 1 | $31.67M |
| 4 | Ppd Development Lp | 6 | $31.12M |
| 5 | L3 Technologies, Inc. | 1 | $22.00M |
| 6 | Technical Resources International, Inc. | 6 | $21.80M |
| 7 | Abbott Laboratories | 1 | $21.01M |
| 8 | Paratek Pharmaceuticals, Inc | 1 | $17.47M |
| 9 | Ossium Health, Inc. | 1 | $12.39M |
| 10 | Rho Federal Systems Division Inc | 1 | $8.00M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75N93019C00053?
Contract 75N93019C00053 is a federal contract awarded to Duke University by Department Of Health And Human Services on July 1, 2024 for $10.48 million of work classified under RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY). It has been modified 5 times since the base award.
Who won contract 75N93019C00053?
Duke University won contract 75N93019C00053 from Department Of Health And Human Services.
How much is contract 75N93019C00053 worth?
Contract 75N93019C00053 has obligated $10.48 million to date, with a total potential value of $141.34 million if all options are exercised.